about
Mutations in SIPA1L3 cause eye defects through disruption of cell polarity and cytoskeleton organizationTwist2: role in corneal stromal keratocyte proliferation and corneal thicknessPostoperative glaucoma following infantile cataract surgery: an individual patient data meta-analysis.Port-wine vascular malformations and glaucoma risk in Sturge-Weber syndrome.Exome sequencing in developmental eye disease leads to identification of causal variants in GJA8, CRYGC, PAX6 and CYP1B1.Novel SOX2 partner-factor domain mutation in a four-generation familyCASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypesOckham's razor revisited: decreased visual acuity secondary to keratoconus in a patient with intracranial hypertension.Primary congenital glaucoma outcomes: lessons from 23 years of follow-up.Objective perimetry using the multifocal visual evoked potential in central visual pathway lesions.Sporadic and Familial Congenital Cataracts: Mutational Spectrum and New Diagnoses Using Next-Generation Sequencing.Chromosomal rearrangements and novel genes in disorders of eye development, cataract and glaucoma.Paediatric uveal melanoma.The impact of the Virtual Ophthalmology Clinic on medical students' learning: a randomised controlled trialIncidence of Intraocular Pressure Elevation following Intravitreal Ranibizumab (Lucentis) for Age-related Macular Degeneration.Study of the efficacy of intravenous tissue plasminogen activator in central retinal artery occlusion.Improved refractive outcome for ciliary sulcus-implanted intraocular lenses.Retrospective review of pars plana versus anterior chamber placement of Baerveldt glaucoma drainage device.Elevated Intraocular Pressure in Patients Undergoing Penetrating Keratoplasty and Descemet Stripping Endothelial Keratoplasty.Efficacy and Safety of Saffron Supplementation: Current Clinical Findings.Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial.Dietary modification and supplementation for the treatment of age-related macular degeneration.A systematic review of best practices in teaching ophthalmology to medical students.Uveal Effusion: Clinical Features, Management, and Visual Outcomes in a Retrospective Case Series.Changing patterns in paediatric optic atrophy aetiology: 1979 to 2015.Changing refractive outcomes with increasing astigmatism at longer-term follow-up for infant cataract surgery.Biochemical analysis of the living human vitreous.Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.Choroidal melanoma: a review of the experience of the Sydney Eye Hospital Professorial Unit 1979-1995.Management of intraoperative tilting of the scleral-fixated intraocular lens in classical aniridia.Ecstasy induced acute bilateral angle closure and transient myopia.Test-retest variability of multifocal visual evoked potential and SITA standard perimetry in glaucoma.Bilateral naevus of Ota with choroidal melanoma and diffuse retinal pigmentation in a dark skinned person.Autoimmune retinopathy associated with intravesical BCG therapy.The importance of electrophysiology in revealing a complete homozygous deletion of KCNV2.Total hyphema following postoperative enoxaparin (Clexane).Acetazolamide in retinoschisis: a prospective study.Identifying preperimetric functional loss in glaucoma: a blue-on-yellow multifocal visual evoked potentials study.Axonal loss and myelin in early ON loss in postacute optic neuritis.Microphthalmia, anophthalmia, and coloboma and associated ocular and systemic features: understanding the spectrum.
P50
Q28118377-6A2024FF-AF87-4BBF-AA21-038E1F21EB7BQ28593948-581282AA-B14B-4AC5-AF8A-E47F37AF8CC8Q30830624-2F983305-230B-44F7-AD6B-16AAE498B334Q33493705-1F82C8B7-F0F6-4528-B5DB-24117A04BCAFQ33765236-7EB60AF5-B7AB-4CD2-9921-9AC2E36FE1B8Q34327268-B9EC902C-CAC8-4B44-94B9-3ECB0CEC2658Q34329072-180A6139-D983-452A-B193-59BB476FA226Q34710076-66B44D1E-0C6E-4DB4-A7B1-15EFA5D72CA3Q35551586-CD257D04-C108-488A-A065-A5C7898BD4CDQ35593229-810ACCB9-67D1-4D3C-AF21-3A9EE19C3D7FQ36675879-F57A538A-C01F-44A9-A2E6-17A47E650E65Q37220091-55CEACFF-E5F8-4C10-B061-EFF6F6F4E5FBQ37242942-7333BE88-3E2A-4971-80D8-87752A3C4CBAQ37251028-F098F291-3430-4E65-953E-E4DB6AF5DB9BQ37604259-5F94FB76-9921-4782-84A1-75AB7B12AB3DQ37825983-46521DB0-3A2D-4C6D-878E-BAF69DD3257AQ37971176-C557D14C-16F0-4D25-AD1F-8F7BC3937F04Q38115906-C07AC33C-C7C6-4559-A7B5-DCEC0DED75F1Q38402345-06B44EFA-D83B-4442-8A4C-6F186E944255Q38421723-E7B3E299-2ADB-49AE-A84B-ABF13DD2E92CQ38487889-A4F5FC16-3837-41B0-AEAD-1D6652C8CBB9Q38529695-9C0405D8-9F09-4608-9CE6-F11A3328F654Q38585474-1FD45D0F-D598-4A6D-BEE3-DBD4958C0A29Q38628655-E7DB93DE-D2FE-4792-979C-98D8159BE994Q38755930-F1EDBA20-BB61-4E2E-B521-E1F800714341Q38897732-4BA022F5-D566-4759-BC6A-2CB4F1E5F465Q39986751-91300931-5E6F-469D-9E09-CBF73D20676CQ40358735-740B1DE2-B8F1-4C28-8771-E122B6C1A9A7Q41434469-9F458355-E42F-423E-8FB6-A55961C48B4FQ42410040-602CFCEB-4E81-49B0-BF8A-5BAEB92D08F8Q42410227-B228A089-5515-46BA-8CFB-FC23E635BCEFQ42638919-14C8998D-B7B2-47A5-94D2-BAF456903F36Q43006730-0AE0E199-68CA-4C86-A8B2-7D6CE4EB1D7DQ43007036-8999B653-56AC-4C7D-8CE0-058311F89804Q44237493-EA334C4F-EC08-4446-87F8-CB76E3ED27F3Q45053148-2E0A81E0-864C-45CE-9EB7-39CB86AA8FC5Q45911409-E8CE4B92-297A-4690-9849-191B387AEF99Q46036443-639DE9FF-CEE0-45A7-83B5-C727AF79CD35Q46339732-5DEDB1EE-8A9B-4E0D-862B-24294225671FQ46515546-453A8E7F-4507-4050-90B8-0A45638DBA75
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-6763-8119
@en
name
John Grigg
@ast
John Grigg
@en
John Grigg
@es
John Grigg
@nl
type
label
John Grigg
@ast
John Grigg
@en
John Grigg
@es
John Grigg
@nl
prefLabel
John Grigg
@ast
John Grigg
@en
John Grigg
@es
John Grigg
@nl
P106
P1153
7007015890
P31
P496
0000-0002-6763-8119